5 Things FDA considers while approving a drug

5 Things FDA considers while approving a drug, For your patients, safe and effective drugs are crucial. Therefore, here are five things to know how the FDA approves medicine.


1. Discovery & Screening of your molecule

The feeling is familiar to all pharmaceutical researchers. Sometimes the elusive molecule must exist — one which inhibits or activates this enzyme the way it wants and does not cause unwanted side effects. But it’s another question to find. For small molecular medicinal products — the cornerstone of the drug industry — long-term and costly testing is needed to select promising candidates from the wide range of natural and synthetic compounds that are available.

It begins when medicine is investigated and examined. New drugs are usually tested before humans on animals. In some instances, additional information on the safety of the compound under examination is gathered from various species.

2. Submitting IND Application

The investigational new drug application (IND) is forwarded to the FDA by the drug sponsor based on the first test results. The application must include the composition of the drug and its production details. The FDA offers a plan for human pharmaceutical testing. The FDA is reviewing this plan to determine whether the study proposed puts human subjects at risk of disease or injury, which is unreasonable and significant.

Understanding an Investigational New Drug

Investigational New Drugs (INDs) fall into two categories:

  • Commercial: mainly submitted by companies seeking marketing authorisation for a new drug.
  • Research (non-commercial): the majority of INDs are filed for non-commercial research and are of three main types – Investigator IND, Emergency Use IND, and Treatment IND.

3. Conducting Clinical trials

In general, a clinical trial in humans involves three phases.

  • Phase 1 highlights safety. 20-80 healthy volunteers typically are involved.
  • Phase 2 emphasizes efficacy and typically involves hundreds of patients with a particular condition or disease.
  • Phase 3 typically includes thousands of patients and is used to collect more safety and efficacy information for various populations and doses.

Clinical studies are studies carried out in individuals that are intended to evaluate a medical, operative or behavioral procedure. They are the primary way for researchers to determine if new treatments (for example a pacemaker) are safe and effective in humans, as is a new medication or diet or a medical device. A clinical trial is frequently used to learn whether a new treatment is more effective and/or less harmful than normal therapy.

4. Application Review & Inspection

Following the clinical trials, the FDA carefully monitors all test data for animals and humans, reviews information on the marking of medicine and examines the facilities to manufacture the medicine to see whether the new medicine is safe and effective.

5. Safety Monitoring

Because all drug effects can not be predicted during clinical trials, it is crucial to monitor the security issues after medicines are placed on the market. The role of the security system for the FDA after marketing is to detect adverse events and, when necessary, take regulatory action.

These are five things you must be aware of about the process of drug approval.

5 Things FDA considers while approving a drug.

Rajat Singhhttps://bioinformaticsindia.com
Rajat Singh is the chief Author at Bioinformatics India, he has been writing for the past 3 years and has a special interest in SEO, Technology, Health, Life Sciences and gaming.

Get in Touch

Comments are closed.

Related Articles

Get in Touch


Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest Posts